Kura Oncology

(NASDAQ) KURA

Current Price$8.66

Market Cap$778.55M

Since IPO (2015)-42%

5 Year-59%

1 Year+36%

1 Month-6%

Kura Oncology Financials at a Glance

Market Cap

$778.55M

Revenue (TTM)

$71.64M

Net Income (TTM)

-$294.57M

EPS (TTM)

-$3.35

P/E Ratio

-2.62

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$8.66

Volume

1,795,410.95

Open

$8.76

Price

$8.66

Volume

1,795,410.95

Open

$8.76

Previous Close

$8.77

Daily Range

$8.56 - $9.21

52-Week Range

$5.45 - $12.49

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$8.66

Volume

1,795,410.95

Open

$8.76

Previous Close

$8.77

Daily Range

$8.56 - $9.21

52-Week Range

$5.45 - $12.49

Estimated Earnings Date

Aug 6, 2026

KURA News

KURA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kura Oncology

Industry

Biotechnology

Sector

Health Care

Employees

260

CEO

Troy E. Wilson, PhD

Website

www.kuraoncology.com

Headquarters

San Diego, CA 92130, US

KURA Financials

Key Financial Metrics (TTM)

Gross Margin

95%

Operating Margin

-4%

Net Income Margin

-4%

Return on Equity

-125%

Return on Capital

-58%

Return on Assets

-45%

Earnings Yield

-38.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$778.55M

Shares Outstanding

88.77M

Volume

1.80M

Avg. Volume

1.64M

Financials (TTM)

Gross Profit

$67.43M

Operating Income

-$303.63M

EBITDA

-$275.83M

Operating Cash Flow

-$64.06M

Capital Expenditure

-$6.64M

Free Cash Flow

-$70.70M

Cash & ST Invst.

$667.24M

Total Debt

$20.46M

Kura Oncology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$18.27M

+29.5%

Gross Profit

$17.65M

+25.1%

Gross Margin

96.62%

N/A

Market Cap

$778.55M

N/A

Market Cap/Employee

$4.05M

N/A

Employees

192

N/A

Net Income

-$73.33M

-27.7%

EBITDA

-$78.46M

-21.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$556.55M

-12.9%

Accounts Receivable

$13.65M

-72.0%

Inventory

$843.00K

N/A

Long Term Debt

$22.99M

+48.1%

Short Term Debt

$1.28M

-66.5%

Return on Assets

-45.14%

N/A

Return on Invested Capital

-57.66%

N/A

Free Cash Flow

-$85.98M

-19.1%

Operating Cash Flow

-$85.85M

-19.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

REPLReplimune Group, Inc.

REPLReplimune Group, Inc.$9.46-4.16%

PROKProKidney Corp.

PROKProKidney Corp.$1.79-3.51%

EYPTEyePoint Pharmaceuticals, Inc.

EYPTEyePoint Pharmaceuticals, Inc.$11.78-3.92%

PRMEPrime Medicine, Inc.

PRMEPrime Medicine, Inc.$3.08-11.38%

SVRASavara Inc.

SVRASavara Inc.$5.08-4.15%

BCAXBicara Therapeutics Inc. Common Stock

BCAXBicara Therapeutics Inc. Common Stock$20.05-1.78%

RZLTRezolute, Inc.

RZLTRezolute, Inc.$4.30-4.77%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.32-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$4.98-0.16%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.71-0.14%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.37+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.67-0.13%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.01+0.12%

BMNRBitmine Immersion Technologies

BMNRBitmine Immersion Technologies$15.90-0.11%

Questions About KURA

What is the current price of Kura Oncology?

Kura Oncology is trading at $8.65 per share.

What is the 52-week range for Kura Oncology?

Over the past 52 weeks, Kura Oncology has traded between $5.45 and $12.49.

How much debt does Kura Oncology have?

As of the most recent reporting period, Kura Oncology reported total debt of $24.27M.

How much cash does Kura Oncology have on hand?

Kura Oncology reported $39.08M in cash and cash equivalents in its most recent financial results.

What is Kura Oncology’s dividend yield?

Kura Oncology does not currently have a dividend yield.

Kura Oncology

Kura Oncology Financials at a Glance

KURA News

Kura (KURA) Revenue Drops 61%

2 Incredible Growth Stocks to Buy Hand Over Fist

Why Kura Oncology Stock Is Sliding Today

Why Kura Oncology Is Skyrocketing Today

3 Beaten-Down Biotech Stocks: Can They Bounce Back?

Here's Why Kura Oncology Fell Today

KURA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Kura Oncology

KURA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Kura Oncology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About KURA

What is the current price of Kura Oncology?

What is the 52-week range for Kura Oncology?

How much debt does Kura Oncology have?

How much cash does Kura Oncology have on hand?

What is Kura Oncology’s dividend yield?

Premium Investing Services